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ABSTRACT. Novel enantiopure pseudopeptide models containing a central -(β-lactam)-(Aa)- scaffold 
characterized by the combined presence of an α-alkyl-α-amino-β-lactam (i+1) residue and a α-
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 2 
substituted (i+2) amino acid have been readily synthesized from α-alkyl serines. The conformational 
analysis of such β-lactam pseudopeptides conducted in CDCl3 and DMSOd6 solutions using 1D and 2D-
NMR techniques revealed an equilibrium between β-II turn and γ-turn conformers, which was 
ultimately modulated by the relative configuration of the -(β-lactam)-(Aa)- residues. Long range chiral 
effects on the α-lactam pseudopeptide conformers were also found when two (i) and (i+3) chiral 
residues were attached to the termini of a central -(β-lactam)-(Aib)- segment. In such mimetics, 
heterochiral (i) and (i+3) residues reinforced a β-II turn conformer, whereas homochiral corner residues 
stabilized an overlapped  β-II/ β-I double turn motif. No  β-hairpin nucleation was observed in any 
instance. In good agreement with the conformers found in solution, β-turned and open structures were 
also characterized by X-ray crystallography. Relative stabilities of the different conformers were 
estimated computationally at a B3LYP/6-31++G** calculation level and, finally, a conformation 
equilibrium model based on steric inter-residual interactions around the –(β-lactam)-(i+2)– segment 
was proposed to account for the observed chiral effects. 
KEYWORDS. Reverse-turn mimics; β-Lactams; β-Turns; γ-Turns; NMR spectroscopy. 
 
Introduction 
Chirality is at the origin of the regular folding patterns occurring in proteins and natural peptides. It is 
well known that short “all-L” peptides may experience dramatic changes in their backbone 
conformation due to the replacement of a single residue by an achiral unit or a D-configuration amino 
acid.1 This phenomenon was first found in natural peptides and is now widely used as a strategy to 
design peptidomimetics stabilizing reverse turn motifs such as β-turns2 1 and γ-turns3 2 (Figure 1, top). 
Indeed, changing the configuration of some backbone residues in functional short peptides may result in 
increased potency, altered selectivity4 or improved proteolytic stability. Furthermore, these effects can 
become amplified when conformationally constrained lactam scaffolds 3 incorporating interresidual 
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 3 
bridges within contiguous CαH and NH positions (Freidinger lactams)5 are embedded in the native 
peptide backbone (Figure 1, bottom). Formation of more complex structures, such as the doubly 
hydrogen-bonded β-hairpins 3 (antiparallel β-sheet nucleators) is also strongly dependent on the 
configurations of the terminal residues (i) and (i+3).6  
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Figure 1. Top: peptides folded into β-turn (1) and γ-turn (2) motifs. Bottom: Freidinger’s lactam 
peptidomimetics (3), and β-LSAD concept to design minimally scaffolded β-lactam pseudopeptides 4, 
differing from the parent peptides in a single carbon atom. 
Unfortunately, most of the (i+1)-(i+2) dipeptide lactam surrogates used routinely as turn mimetics7 
possess comparatively large external fragments and their restraint elements (cycles) and recognition 
groups (R1 and R2) are often crammed in the scaffold.8 Alternatively, the studies carried out on proline 
peptides9 were only of limited success, because of their inherent ring-puckering. This makes it very 
difficult to interpret the stereoelectronic interactions arising from the chirality effect of residues 
neighboring the lactam moiety. Hence, a scaffold size reduction strategy intended to design “minimal” 
short peptide models becomes particularly attractive in terms of design simplicity and folding 
interpretation.  
In our first accomplishment in this area10 we introduced the β-lactam peptides 4 containing a central 
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 4 
α-alkyl-α-amino-β-lactam ring placed as the (i+1) residue.11 This approach, termed “β-Lactam 
Scaffold-Assisted Design” (β-LSAD), involved the formal insertion of a single carbon atom (Cα-H + H-
N → Cα-CH2-N) in the native peptide to form “minimal” β-lactam pseudopeptides 4, which displayed a 
set of interesting structural features. Firstly, the linear disposition of the Cα, N and Cα’ atoms within 
the β-lactam ring confers to peptidomimetics 4 a high potential for β-hairpin nucleation. Secondly, they 
possess a ψ(i+1) dihedral angle fixed at 120º by the β-lactam ring, which prevents the formation of type-I 
and/or type-III β-turns (both with ψ(i+1) near –30º) and favors only the β-II-turn/γ-turn conformational 
equilibrium.12 Indeed, a preliminary conformational study of β-LSAD pseudopeptides containing a 
glycine (i+2) residue (4; R2= H) conducted in our laboratory confirmed their strong bias towards 
forming type-II β-turns which survive even in the presence of the highly coordinating solvent 
DMSO.10(a) Finally, α-alkyl-α-amino-β-lactam peptides are expected to be chemically much more stable 
than common α-amino-β-lactam antibiotics, which undergo easy ring-opening to β-amino acid 
derivatives. This transformation usually involves an AdN nucleophilic attack onto the C=O sp2 carbon 
atom following the Bürgi-Dunitz trajectory.13 In β-lactams 4 such a trajectory is hindered by the α-
substituents at both sides of the 2-azetidinone plane, thus difficulting the ring-opening reaction with 
respect to other α-monosubstituted β-lactam analogues.14 Recently, the surprisingly high “amidicity” of 
monocyclic β-lactams has also been invoked to account for their chemical stability.15 
As mentioned above, only the solution conformation of short β-lactam pseudopeptides containing a 
central –(β-Lactam)-(Gly)– core has been studied so far and the possible  β-turn stabilizing (or 
destabilizing) effect exerted by the chiral α-amino acid residues neighboring the β-lactam nucleus 
remains to be explored. Herein we report the synthesis and detailed conformational analysis of three 
families of β-lactam pseudopeptide models designed to show the chiral effects of residues (i) (i+2) and 
(i+3) on the folding of short β-lactam peptides 4 in solution and in the solid state. Finally, we further 
examine the ability of this motif to nucleate a β-hairpin, the shortest  β-sheet structure. 
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 5 
Results and Discussion 
Design and Synthesis of β-Lactam Pseudopeptide Models. Short pseudopeptide models 5-7  
(Figure 2) with homogeneous (R) configuration at the Cα stereocenter of the β-lactam ring were 
selected for development because they are reminiscent of constrained natural L α-amino acid residues.16  
Configurationally related β-lactam peptides 5 and 6 containing a single additional stereocenter at 
residue (i+2) were designed to carry terminal groups with different steric demands. Accordingly, 
mimetics 5 [Ac-(α-Me-β-Lactam)-Aa-Me] represented the smallest capped β-lactam dipeptide 
structures containing three peripheral methyl groups, whereas mimetics 6 [Boc-(α-Bn-β-Lactam)-Aa-
Aib-OH] had a larger central benzyl group and bulkier achiral N- and C-terminal groups (Boc and Aib-
OH). Finally, pseudopeptides 7 [Boc-Ala*-(α-Bn-β-Lactam)-Aib-Ala*-NH2] were designed to ascertain 
the chiral effect of two additional stereocenters at the (i) and (i+3) alanine residues on the possible β-
hairpin nucleation. 
N
O
Me
N
R2R1
5
O
H
N
O
N
R2R1
6
O
O
H
N OH
O
N
O
H OH
N
O
N
7
O
H
N
N O
H
H
R4 R3
O
NH2
R2 R1
O
O Ph
Ph
10 (R= Me)
11 (R= Bn)
H2N OH
CO2Me
Rref. 18
Ns =
NO2
S
O O
CO2HNO
R
NsHN
R2R1
!'
8 (R= Me)
9 (R= Bn)
!
5-7
 
Figure 2. Top: β-Lactam pseudopeptide models 5-7 selected to study the chiral effect of residues (i), 
(i+2) and (i+3) on the peptide folding. Bottom: Synthesis of the β-lactam dipeptide scaffolds 8-9. 
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 6 
The enantiopure scaffolds 8-9 required to form the central –(i+1)-(i+2)– pseudopeptide segments 
were easily obtainable from the corresponding α-alkylserinates17 10-11 according to an operatively very 
simple method developed in our laboratory.18 Tables 1 and 2 collect the details of the transformation of 
the dipeptide scaffolds 8, 9 and 14 into the target β-lactam pseudopeptide models. 
As shown in Table 1, the synthesis of pseudopeptides 5 and 6 required the coupling of the C-terminal 
carboxylic acid group in 8 and 9 with methylamine and α-aminoisobutiric benzyl ester, respectively. 
Formation of N-methylamides 12a-e from non-hindered β-lactam carboxylic acid precursors was best 
performed using the mixed anhydride method assisted by isobutyl chloroformate and N-
methylmorpholine, whereas couplings involving hindered Aib residues were most efficiently 
accomplished with EEDQ19 reagent (products 13, 15, 16 and 7a-d). Denosylation of compounds 12-13 
proceeded smoothly with thiophenol20 in the presence of potassium carbonate to afford the intermediate 
α-amino-β-lactams, which were trapped in situ with acetic anhydride or di-tert-butyl dicarbonate to 
provide the desired mimetic models 5 or the analogs 6 after hydrogenolytic deprotection of the C-
terminal benzyl ester. Stereochemical integrity was maintained in all transformations and no 
epimerization of the α’ stereocenter could be detected via NMR and HPLC analysis of the reaction 
crudes. Following a similar protocol (Table 2), mimetics 7 were obtained in good overall yields from the 
α’,α’-dimethyl-β-lactam 14 after consecutive coupling with N-protected alanines 17 and alaninamides 
18 using, respectively, the EEDQ and HATU/HOAT21 reagents. 
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 7 
Table 1. Preparation of β-Lactam Peptidomimetics 5 and 6. 
N
O
Me
N
R2R15
Me
O
H
N
O
Me
H
CONHMeN
O
Me
NsHN
R2R112
iBuO2CCl, NMM
then H2NMe
PhSH, K2CO3,
then Ac2O!' !'8
2) H2, Pd-C
H-Aib-OBn,
EEDQ
COAibOBnN
O
NsHN
R2R113
!'
!'
9 NO
N
R2R16
tBuO
O
H
N OH
O
H O
Ph
1) PhSH, K2CO3,
    then (Boc)2O
Ph
 
R1 R2 Config. Cα’ Product Yield (%) Product Yield (%) 
H H ---- 12a 80 5a 84 
Me H (R) 12b 58 5b 72 
H Me (S) 12c 59 5c 81 
Ph H (R) 12d 78 5d 89 
H Ph (S) 12e 85 5e 94 
Me Me ---- 12f 75 a) 5f 82 
Me H (R) 13b 79 6b 79 
H Me (S) 13c 70 6c 80 
Ph H (R) 13d 55 6d 82 
H Ph (S) 13e 66 6e 80 
Me Me ---- --- --- 6f b) 92 
a) EEDQ reagent was used as the amide formation reagent. b) The product was prepared from acid Boc-
(β-Lactam)-Aib-OH, which was coupled to H-Aib-OBn and submitted to hydrogenolysis. 
 
Table 2. Preparation of β-Lactam Peptidomimetics 7. 
CO2MeNO
NsHN
14
Ph
1) LiOH, THF
N
O
N
7
O
H
N
N O
H
H
R4 R3
O
NH2
R2 R1
tBuO
O Ph
CO2MeNO
N
15 (R1= H, R2= Me) 83%
16 (R1= Me, R2= H) 85%
O
H
BocHN
R2 R1 Ph
1) PhSH, K2CO3,
2) HATU,
!''
!'''
CO2HBocHN
R2 R1
H2N CONH2
R4 R3
18
2) EEDQ,
17  
R1 R2 Config. Cα’’ R3 R4 Config. Cα’’’ Product Yielda (%) 
H Me (R) H Me (R) 7a 80 
H Me (R) Me H (S) 7b 65 
Me H (S) Me H (S) 7c 73 
Me H (S) H Me (R) 7d 77 
a) Overall yield from 15, 16.  
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 8 
Solution Conformation of β-Lactam Peptides 5-6 with a Chiral (i+2) Residue. With the model β-
lactam peptides in hand, we first addressed the NMR conformational analysis of the simplest families 5 
[Ac-(α-Me-β-Lactam)-Aa-Me] and 6 [Boc-(α-Bn-β–Lactam)-Aa-Aib-OH] in order to characterize the 
presumably more populated β–II turn conformers in solution and to assess the possible stabilizing or 
destabilizing effects exerted by the chiral Aa residues on the conformer equilibrium. Although water 
was considered first as the most biologically meaningful medium for the study, finally DMSOd6 solvent 
was chosen for practical reasons to ensure solubility. In the case of peptides 5a-f, however, the recurrent 
overlapping of NH amide signals in dimethylsulfoxide precluded a straightforward interpretation of the 
results and CDCl3 was used as solvent.   
Solutions of each peptide 5a-f and 6a-f (5 x 10–3 M) yielded sharp, well-resolved 1H-NMR spectra 
consisting of single sets of signals in both solvents. All protons were unambiguously assigned from 
DQF-COSY and HMBC spectra (Supporting information Figures S1-S10). Chemical shift variations 
upon solvent change and 1H-NMR thermal coefficients22 for the exchangeable amide protons of the 
pseudopeptides in DMSOd6 solutions were determined over a temperature range of 300-325K at 5K 
intervals (Table 3). An inspection of the data recorded immediately revealed a totally different 
deshielding for the β-lactam N2H amide protons and the N7H protons of the (i+3) residue, suggesting 
the formation of a turned conformer in most of the cases with the N7H amide protons participating in the 
intramolecular hydrogen bond network of the β-lactam peptides and the N2H protons exposed to the 
solvent. This was evident from the analysis of thermal coefficients in DMSOd6 (see Table 3, two right 
hand columns) showing absolute values in the range –2.3 to –4.9 ppb/K for N7H protons, whereas 
amides and carbamates N2H gave larger thermal coefficients (up to –8.9 ppb/K). Consistently, the 
solvent change from nonacceptor CDCl3 to acceptor DMSOd6 resulted in a very small chemical shift 
variation for N7H amides in all peptides (0.1 – 1.1 ppm), but in a significantly larger downfield shift (2.3 
– 2.8 ppm) in N2H β-lactam amides. While seeking more insight into the conformational differences 
between the β-lactam peptide diastereomers with (i+2) chiral α-amino acid residues (Table 3, entries 2-
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 9 
5 and 8-11), we noticed that the thermal coefficients of the N7H protons where routinely larger for 
(i+2)-(S) diastereomers (5c, 5e and 6c, 6e) than for (i+2)-(R) ones (5b, 5d and 6b, 6d) and, furthermore, 
this effect was appreciably enhanced in pseudopeptides containing the bulkier phenylglycine residues 
(compare entries 4-5 and 10-11). This lower exposure of the (R) diastereomers to the DMSOd6 
coordinating solvent was consistent with the tight intramolecular N7H…O=C hydrogen bonding of β-
turned β-lactam peptides 4 (Figure 1), whereas the weaker hydrogen bonds of the (S) diastereomers 
(entries 3, 5, 9 and 11) suggested a partial folding of the peptide backbone into γ-turned conformers or 
open conformers possessing more exposed amide protons. Finally, the β-lactam pseudopeptides with 
nonchiral Gly or Aib (i+2) residues (entries 1, 6, 7 and 12) exhibited only very shielded N7H protons in 
DMSOd6, consistent with their likely participation in stable β-turns.  
 
Table 3. Amide Proton 1H-NMR Chemical Shifts (δ) and Thermal Coefficients (Δδ/ΔT) for β-Lactam 
Peptidomimetic Models 5a-f and 6a-f. 
N
N
H
Me
H
NMe
R R
O
O
O
5 6
4
7
1
3
2
HR
HS
Me
8
5
3Ar
N
N
H
OH
R R
O
O
O
Me
5 6
8
4
7
3 HR
HS Me
N
H
O
O1
2
6
SR
!' !'
!
 
Entry Comp R5 R6 Config C α’ N2H(δ)a N7H(δ)a N2H(Δδ /ΔT)b  N7H(Δδ /ΔT)b  
1 5a H H ---- 5.63 (+2.77) 8.09 (+0.08) –5.3 –3.2 
2 5b Me H (R) 5.60 (+2.72) 8.08 (+0.18) –4.8 –3.4 
3 5c H Me (S) 5.57 (+2.66) 7.94 (+0.29) –4.5 –3.9 
4 5d Ph H (R) 5.64 (+2.77) 8.41 (+0.16) –5.0 –4.0 
5 5e H Ph (S) 5.62 (+2.52) 7.12 (+1.15) –4.5 –4.9 
6 5f Me Me ---- 5.55 (+2.81) 8.19 (+0.16) –6.5 –3.9 
7 6a H H ---- 4.89 (+2.21) 7.82 (+0.01) –8.3 –2.3 
8 6b Me H (R) 4.76 (+2.84) 7.93 (+0.03) –8.9 –2.8 
9 6c H Me (S) 4.90 (+2.29) 7.83 (+0.10) –9.0 –3.0 
10 6d Ph H (R) 4.85 (+2.69)  8.18 (+0.14) –8.3 –3.1 
11 6e H Ph (S) 4.94 (+2.32) c 7.85 (+0.56) –8.9 –4.2 
12 6f Me Me ---- 4.84 (+2.73) 7.76 (+0.10) –8.6 –2.5 
aChemical shifts (ppm) measured in CDCl3; Values in parentheses represent variations of the chemical 
shift when the CDCl3 solvent was changed to DMSOd6. bThermal coefficients in ppb/K measured in 
DMSOd6. cA mixture of conformers was observed at room temperature in CDCl3, which coalesced in 
DMSOd6.  
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Next, relevant noncontiguous inter-proton distances for peptides 5-6 were calculated following the 
ISPA (Isolated Spin-Pair Approximation) method23 from the integration of key NOESY or ROESY 
cross-peak signals recorded at 300K (500MHz) at mixing times of 200-400 ms (Supporting information, 
Tables S1 and S2; Figures S15 and S16). 
Some expansions of the NOESY spectra of 5d-e (in CDCl3) and 6d-e (in DMSOd6), incorporating a 
chiral phenylglycine (i+2) residue, are shown in Figure 3 as an example. The spectra gave rise to a 
number of NOE contacts, including the excellent diagnostic correlation peaks provided by the pro-R and 
pro-S diastereotopic C4 protons placed, respectively, at the upper and lower faces of the β-lactam ring, 
as depicted in the figure. Only the 4HR proton gave a characteristic strong NOE contact (cross-peak a) 
with the 3Me singlet in peptides 5 and with the benzylic moiety 3/3Ar in peptides 6. Conversely, the 
4HS proton oriented to the lower face of the azetidin-2-one ring plane was used to monitor the 4HS –N7H 
distances (cross-peak b) and to estimate the preferred formation of canonical β-II turns (≈ 2.5–2.8Å), 
distorted γ-turns (≈ 3.8–4.0Å) or open conformers (> 4 Å). Additionally, the orientation of the R5 and R6 
substituents of the chiral (i+2) residue relative to the  β-lactam ring could be established on the basis of 
the distances of some of their key protons to 4HR and 4HS (cross-peaks c and d). In the case of 6d, the 
abnormal shielding of 5Ar ortho protons (6.52 ppm) arising from the diamagnetic effect of the 
neighboring benzylic 3Ar ring provided a further indirect sign of β-turn conformation. Finally, as none 
of the peptides 5-6 gave measurable 4HR/N7H correlation cross-peaks, a significant participation in the 
conformational equilibrium of inverse γi-turn  β-lactam pseudopeptides with the (i+2)-(i+3) branch 
oriented toward the top side of the azetidinone ring was ruled out (see empty boxes in Figure 3).  
From the inter-proton distances collected in Figure 3, a regular chiral effect trend could be observed 
for the β-turn/γ-turn equilibrium as the α’-(R) configuration of peptides 5d/6d changed to α’-(S) in their 
diastereomers 5e/6e. Indeed, the average 4HS –N7H distances (cross-peak b) were significantly shorter 
for 5d and 6d (2.6 and 3.0 Å) than for their respective isomers 5e and 6e (3.8Å and >4 Å), suggesting  
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Figure 3. Expansion of the NOESY spectra of pseudopeptides 5d-e in CDCl3 (top) and 6d-e in DMSOd6 
(bottom) showing a preferred β-II turn conformation (left hand) and a  γ-turn conformation (right hand). 
Key NOE correlations with the upper (4HR) and lower (4HS) sides of the β-lactam ring plane are 
highlighted inside boxes. Empty boxes show the expected position of alternative b cross-peaks with 4HR 
protons.  Model figures show energy-minimized SYBIL molecular mechanics structures restrained with 
NOESY inter-proton distances (± 0.3Å) (Supporting information Tables S1-S2). 
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that in the latter cases β-turns were weakened or broken in favor of γ-turns. This assumption was 
further supported by the close distances of the CαH5 protons of the (S)-phenylglycine residue to 4HR and 
4HS in 5e/6e and also by the absence of a comparable interaction for CαH6 in 5d/6d. In line with these 
observations, β-lactam pseudopeptides 5b/6b and 5c/6c derived, respectively from (R)-alanine and (S)-
alanine, showed similar β-turn destabilization trends upon (i+2) α’ stereocenter configuration inversion, 
albeit in these cases the chiral effect was less pronounced (Supporting information, Figures S15 and 
S16). Finally, all the β-lactam pseudopeptides with achiral (i+2) residues of glycine (5a/6a) or  α-
aminoisobutiric acid Aib (5f/6f) populated exclusively very stable β-turn conformations and showed no 
tendency to form γ-turns.  
Solution Conformation of β-Lactam Peptides 7 with Chiral (i) and (i+3) Residues. Following the 
same NMR methodology disclosed above, we next studied the conformational behavior of β-lactam 
peptidomimetics 7a-d in DMSOd6 to check the chiral effect of (i) and (i+3) alanine residues on the 
nucleation of β-sheets. The thermal coefficient data collected in Table 4 show that all the (i+3) N8H 
amide protons participate in strong intramolecular hydrogen bonds, likely forming stable β-II turns. 
Interestingly, unlike the “heterochiral” diastereomers 7b and 7d, each “homochiral” diastereomer  
 
Table 4. Amide Proton 1H-NMR Thermal Coefficients (Δδ/ΔT)a for β-Lactam Peptidomimetic 7. 
N N
H
N
H
N
N
H
MeR MeS
O
O O
O
O
O Me
Me H
H
10
11
9!
9
6
8
1
2
3
3!
4
HR
HS
7
5Ar
5
7
 
Entry Comp Config (C3, C9) N2Hb N4H N8H N10Hb N11H 
1 7a (R, R) –7.4 –6.6 –2.3 –2.4 –5.2 
2 7b (R, S) –7.3 –6.7 –2.8 –3.8 –4.1 
3 7c (S, S) –6.3 –5.8 –3.5 –2.5 –5.2 
4 7d (S, R) –7.0 –5.8 –2.5 –4.3 –4.5 
a Thermal coefficients in ppb/K measured in DMSOd6. 
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7a (R,R) and 7c (S,S) showed an additional solvent-shielded N10H terminal trans-amide proton, which 
we hoped would participate as donors of the Boc group in β-hairpin type secondary structures. A more 
detailed examination of the inter-proton distances from ROESY spectra of 7a, however, revealed that 
the actual acceptor of the N10H amide proton was the  β-lactam carbonyl oxygen, thus forming two 
overlapped β-II/β-I turns (Figure 4). In particular, this assumption was further supported by the long 
range N8H–N10H NOE diagnostic cross-peak h observed for the homochiral peptide 7a, but not for the 
heterochiral peptide 7b (for an analogous behavior for diastereomers 7c/7d see Supporting information 
Figure S17). 
 
 
Figure 4. Expansion of the ROESY spectra of pseudopeptides 7a and 7b in DMSOd6 showing two 
overlapped β-turns sharing the β-lactam ring and the N8H–N10H close distance NOE correlation (h). The 
model figure shows the energy-minimized structure restrained with ROESY inter-proton distances (± 
0.3Å) (Supporting information Table S3) 
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Solid State Conformation of β-Lactam Peptidomimetics 5-7. Single crystals of the β-lactam 
pseudopeptides 5e, 5f, 7a and 7d were grown from their solutions in MeOH and were used for low-
temperature X-ray structure determination (Figure 5). A detailed analysis of some key structural 
parameters, Table 5, revealed the formation of well defined β-II turn conformers in all instances, with 
the exception of the (S)-phenylglycine-derived mimetic 5e, which showed an extended backbone 
structure with the (i) acetamido group and the (i+3) phenylglycine N-methylcarbamoyl group lying on 
opposite sides of the plane of the β-lactam ring. Consistent with the extremely destabilized γ-turn 
conformation observed for this pseudopeptide in solution by NMR, no intramolecular hydrogen bond 
was detected in the solid state. Instead, each NH amide group acted as a donor to form intermolecular 
bifurcated hydrogen bonds with the C=O oxygen atom of the β-lactam ring.  
Mimetic models 5f, 7a and 7d containing the (i+2) Aib residue fulfilled all the structural criteria of 
canonical type-II  β-turns in terms of (i)C=O…HN(i+3) hydrogen bond distances (1.9–2.1Å), (i)O…H–N(i+3) 
angles (159º–167º) and the δ pseudodihedral angle formed by the four Cα atoms (5º–14º), which was 
very close to the ideal null value. Only a slight distortion (15-20º) caused by the coplanar arrangement 
of N(i+1), Cα(i+1), N(i+2) and Cα(i+2) atoms around the central β-lactam ring, was observed for the torsion 
angles φ - ψ in residues (i+1)-(i+2) with respect to the ideal values for a type-II β-turn. On the other 
hand, none of the peptides 7a and 7d showed a second hydrogen bond between the terminal Boc and 
NH2 groups denoting the formation of β-sheet structures. In spite of that, the NHtrans terminal amide 
proton of peptide 7a acted as a donor to the β-lactam carbonyl oxygen atom to form a quasycanonical β-
I turn partially overlapping the β-II turn. To the best of our knowledge, this is the first example of such a 
type of double motif in solid pseudopeptide structures.24 
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Figure 5. ORTEP plots (50% probability ellipsoids) of the molecular structures of β-lactam 
peptidomimetics 5e, 5f, 7a and 7d in the solid state. Compound 7a shows overlapping  β-II/β-I turns.  
 
Table 5. Selected Geometric Parameters for β-Lactam Peptidomimetic Models 5e, 5f, 7a and 7d. 
Comp (i)C=O…HN(i+3) (Å)       φ(i+1); ψ(i+1) (º)      φ(i+2); ψ(i+2) (º) δ (º)a (i)C=O…H–N(i+3) (º)b  
5e > 4.0 –39.0(4); 126.6(3) –95.2(4); 134.9(3) –157.0 --- 
5f 1.92(3) –38.3(2); 125.4(2)   90.8(2); –2.8(2)   14.4 160(3) 
7a (β-II) 2.07(3) –39.7(3); 118.9(2)   47.0(4); 30.4(3) –31.3 167(2) 
7a (β-I) 1.87(4)   47.0(4); 30.4(3)   67.2(3); 24.3(3) –77.3 168(5) 
7d  1.97(3) –40.6(3); 123.9(2)   95.4(3); –2.5(3)   15.9 159(3) 
β-II (ideal) 1.8– 2.5          –60; 120           80; 0    0 160 
β-I (ideal) 1.8– 2.5           60; 30           90; 0    0 160 
γ (ideal) 1.8– 2.5           ---; ---           50; –60    0 160 
aPseudodihedral angle formed by the four Cα atoms of the peptide models. bO…H–N angle.  
 
Finally, a rationale for the chiral effect caused by the (i+2) residue on the relative stability of β-II/ γ 
conformers in pseudopeptides 5 was established on the basis of the steric interactions of R1 and R2 
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groups with the carbonyl and methylene groups of the β-lactam ring (i+1). Accordingly, we submitted 
structures 5a-f to a DFT computational optimization25 consisting of a Monte Carlo search (6-31G*), 
followed by structure minimization at the B3LYP/6-31++G** level.26 Energy values collected in Figure 
6 show a general trend for the preferred stabilization (2-3 Kcal/mol) of type II β−turns, over the normal 
γ-turns. As expected, no type-I β−turn could be characterized as a stable energy minimum. In addition, a 
clear chiral-effect destabilizing the β−II turn was apparent in the case of heterochiral (R,S) mimetics 5c 
and 5e with respect to the homochiral (R,R) mimetics 5b and 5d and this energy-difference increased 
when the size of R group was increased from methyl to phenyl. In the latter case, a dramatic inversion in 
the stability of the γ-turn is also observed. Finally, models 5a and 5f bearing respectively achiral (i+2) 
residues of Gly and Aib, displayed very similar relative stability patterns favoring the type β-II 
conformer over the γ-turns, albeit in the later case the energy-difference was lower in the latter case. 
Erel!
Gly
Aib
0.0
5a          5b          5c           5d          5e            5f
0.0 0.0 0.0
2.62.7
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Figure 6. Top: relative zero-energies (Kcal⋅mol–1) of β-II turn and γ-turn conformers for pseudopeptides 
5a-5f. Bottom: steric interactions accounting for the chiral-effect and relative conformer stabilities. The 
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energy values for the isomer pairs 5b-c and 5d-e are referred to the lower energy conformer in each 
case. 
Figure 6 also depicts the Newman projections of models 5 with the β-lactam nitrogen atom and Cα’ 
eclipsed. In homochiral (R,R) isomers the group R can adopt an alternative disposition only when the β-
turn-II conformation is reached, leading to the more stable conformations. The exception to this general 
bias only occurs when the (i+2) residue is heterochiral with respect to the β-lactam (i+1) stereocenter 
and the size-difference between R and the β-lactam α- group is large. For instance, in model 5e with a 
(S)-phenylglycine (i+2) residue, conformer β-II is destabilized by the steric repulsion of the phenyl 
group and the β-lactam carbonyl oxygen atom, resulting in the stabilization of the γ-turn conformer. 
 
Conclusions 
The present work illustrates the intrinsic ability of short β-lactam peptide chains to form β-II and γ-
turn structures in solution. It also emphasizes that “one carbon-scaffolded” β-lactam pseudopeptides 
provide very precise information on the H-bonding pattern in short peptide models, which complements 
prior quantum chemistry and gas-phase laser-desorbed experiments.25(c) 2D NMR experiments 
conducted in solution have provided compelling evidence that β-lactam pseudopeptides 5-6 containing a 
central homochiral –[(R)-β-Lactam-(R)-Aa]– segment behave as betagenic, whereas the heterochiral 
analogues –[(R)-β-Lactam-(S)-Aa]– destabilize β-turn conformations and favor γ-turned peptides, 
especially when the (i+2) Aa residue carries sterically demanding Cα backbone substituent groups. In 
addition, pseudopeptides 7 containing a central betagenic –[(R)-β-Lactam-Aib]– nucleus flanked by 
heterochiral (i) and (i+3) α-amino acid residues do not show a straightforward ability to stabilize β-
hairpins. Instead, the homochiral counterparts show a strong tendency to form unprecedented β-II/β-I 
overlapped double turns around the central β-lactam core. 
In the light of the current results, it can be stated that chirality-driven conformational effect may 
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ultimately determine the preferred type of turn stabilized by β-lactam pseudopeptides. Therefore, the β-
LASD design model, consisting in the incorporation of an intra-residual methylene bridge to frozen 
type-II β-turns, must be applied cautiously to “all-L” peptide natural segments when chiral residues 
neighboring the central β-lactam core are involved. Despite this limitation, the β-LASD design method 
provides a simple steric model that opens up the route for a better understanding of the steric 
interactions driving the shallow β-/γ- transition in larger peptides.   
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Experimental Section    
General Experimental Section. All reactions were carried out under an atmosphere of nitrogen in 
oven or flame-dried glassware with magnetic stirring. Solvents were distilled prior to use. Anhydrous 
tetrahydrofuran (THF) and dichloromethane were distilled, respectively, from sodium 
metal/benzophenone ketyl and from calcium hydride. Reaction products were purified by flash 
chromatography using silica gel 60 (230-400 mesh). Analytical TLC was performed on 0.25 mm silica 
gel 60-F plates and spots were visualized, either with UV light or with the spray reagent 
phosphomolybdic acid-ammonium cerium (IV) nitric-sulfuric acid-water, followed by heating. Melting 
points are uncorrected. 1H NMR and 13C NMR spectra were recorded at 500 MHz and 125.7 MHz 
respectively and are reported as δ values (ppm) relative to residual CDCl3 (δ 7.26), DMSO (δ 2.49) and 
CDCl3 (δ 77.0), DMSO (δ 39.5) as internal standards. Mass spectra were obtained from samples ionized 
under EI (70 eV) or CI conditions and detected using a quadrupole or a TOC mass analyzer, after direct 
injection (HRMS) or GC-MS coupling (column: fused silica gel, 15 m, 0.25 mm, 0.25 nm phase SPB-
5). The preparations and spectroscopic data of compounds 6a, 8a, 9a-f and 14 were reported 
previously.10(a), 18 
 
General Procedure for the Preparation of 1-Carboxyalkyl-3-methyl-3-(2-nitrobenzene 
sulfonylamino)azetidin-2-ones 8b-f: 18 To a solution of (R) methyl 2-methyl-serinate 10 (1.90 mmol, 
0.32 g) and 2-nitrobenzenesulfonyl chloride (NsCl, 4.18 mmol, 0.935 g) in acetonitrile (30 mL) was 
added KHCO3 (9.50 mmol, 0.951 g) and the suspension was stirred at reflux for 16 hours. Then, 
saturated aqueous NaHCO3 (15 mL) was added and the mixture was extracted with EtOAc (3 x 15 mL). 
The organic layer was dried (MgSO4) and the solvents were evaporated at reduced pressure to give pure 
(2R)-2-methyl-2-methoxycarbonyl-1-(2-nitrobenzenesulfonyl)-aziridine. A solution of the aziridine 
(1.51 mmol) and the corresponding  β-(tert-butyldimethylsilyloxy)-ethylamine (1.51 mmol) in dry 
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acetonitrile (30 mL) was stirred at room temperature for 20 hours. Then saturated aqueous NaHCO3 (15 
mL) was added and mixture was extracted with EtOAc (3 x 15 mL), the organic fractions were dried 
(MgSO4) and filtered, and solvents were evaporated in vacuo to give the corresponding β-azaalanine, 
which was purified by column chromatography (hexanes/EtOAc 4:1). To a stirred solution of the β-
azaalanine (1 mmol) in dry THF (15 mL), 2.5 mmol of LiHMDS in THF (1M) were added. After 
stirring for 12 hours, the mixture was washed with a saturated aqueous solution of NaHCO3 (3x10 mL) 
and the aqueous layer was extracted with CH2Cl2. The solvent was evaporated under reduced pressure 
and the crude product was purified by column chromatography (hexanes/EtOAc, 1:7). The intermediate 
obtained was oxidated following two different procedures: 
Oxidation Method A:27 BAIB (1.069 mmol, 0.344 g), TEMPO (0.243 mmol, 0.038 g), and the 
corresponding N-hydroxyethyl-β-lactam (0.486 mmol) were combined in the reaction vessel, and to this 
mixture was added 1:1 acetone-water solution (2 mL). The reaction mixture was stirred for 3h before 
evaporation of the solvents under reduce pressure. The resulting product was purified by column 
chromatography (hexanes/EtOAc, 1:10 or CH2Cl2/MeOH, 10:1). 
Oxidation Method B: The Jones reagent28 (1.48 mmol) was added drop-wise to the solution of the 
corresponding N-hydroxyphenylethyl-β-lactam (0.74 mmol) in acetone (10 mL) at 0°C and the mixture 
was stirred at the same temperature for 2h. The oxidant excess was quenched with iPrOH (10 mL) and 
the dark solid formed was dissolved with H2O (4 mL). The mixture was extracted with EtOAc (3 x 10 
mL) and the combined organic fractions were washed with brine (5 mL). The organic solution was dried 
(MgSO4), evaporated under reduced pressure, and the resulting product was purified by column 
chromatography (MeOH/CH2Cl2, 1:10).  
(3R)-1-[(R)-1-Carboxyethyl]-3-methyl-3-(2-nitrobenzenesulfonylamino)azetidin-2-one (8b): The 
general procedure was followed (Oxidation method A) from N-[(2R)-2-hydroxy-1-methylethyl]-β-
lactam (0.524 mmol, 0.180 g). Yield: 0.160 g (87%); yellowish solid; m.p. 55°C; [α]D25 +7.7 (0.45, 
MeOH); IR (KBr) νmax 3320, 2944, 1747, 1718, 1545, 1169, 832 cm–1; 1H NMR (500 MHz, CD3OD) δH 
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8.22−7.78 (m, 4H), 4.09 (q, 1H, J = 7.2 Hz), 3.72 (d, 1H, J = 5.8 Hz), 3.35 (d, 1H, J = 5.8 Hz), 1.52 (s, 
3H), 1.38 (d, 3H, J = 7.3 Hz). 13C NMR (75 MHz, CD3OD): δ 177.7, 169.4, 149.4, 136.4, 135.0, 133.7, 
131.9, 125.9, 66.5, 54.8, 54.3, 20.5, 16.5. MS m/z (ESI, negative polarity): MS-1: 355.9; MS2(355.9): 
308.8, 200.7, 185.7, 137.8. Anal. calcd. for C13H15N3O7S: C, 43.69; H, 4.23; N, 11.76. Found: C, 43.50; 
H, 4.17; N, 11.49. 
 (3R)-1-[(S)-1-Carboxyethyl]-3-methyl-(2-nitrobenzenesulfonylamino)azetidin-2-one (8c): The 
general procedure was followed (Oxidation method A) from N-hydroxy-(2S)-methylethyl-β-lactam 
(0.350 mmol, 0.120 g). Yield: 0.110 g (88%); white solid; m.p. 58-60°C; [α]D25 −21.3 (0.5, MeOH). IR 
(KBr) νmax 3260, 2901, 1742, 1728, 1543, 1170, 820 cm–1; 1H NMR (500 MHz, CD3OD) δH 8.17−7.83 
(m, 4H), 4.23 (q, 1H, J = 7.5 Hz), 3.63 (d, 1H, J = 5.5 Hz), 3.50 (d, 1H, J = 5.5 Hz), 1.58 (s, 3H), 1.38 
(d, 3H, J = 7.5 Hz). 13C NMR (75 MHz, CD3OD): δ 176.1, 168.1, 147.9, 135.1, 133.6, 132.2, 130.1, 
124.4, 65.0, 52.5, 51.5, 19.3, 14.9. MS m/z (ESI, negative polarity): MS-1: 356.0; MS2(356.0): 200.7, 
137.8; MS3(200.7): 136.8. Anal. calcd. for C13H15N3O7S: C, 43.69; H, 4.23; N, 11.76. Found: C, 43.54; 
H, 4.46; N, 11.47. 
 (3R)-3-Methyl-3-(2-nitrobenzenesulfonylamino)-1-[(R)-1-phenyl-carboxymethyl]azetidin-2-one 
(8d): The general procedure was followed (Oxidation method B) from N-hydroxy-(2R)-phenylethyl-β-
lactam (1.43 mmol, 0.58 g). Yield: 0.330 g (55%); yellowish powder; m.p. 115°C; [α]D25 56.1 (0.7, 
MeOH); IR (KBr) νmax 3050, 2934, 1749, 1725, 1530, 1156, 802 cm–1; 1H NMR (500 MHz, CD3OD) δH 
8.24−7.32 (m, 9H), 5.37 (s, 1H), 3.97 (d, 1H, J = 6.0 Hz), 3.08 (d, 1H, J = 6.0 Hz), 1.41 (s, 3H). 13C 
NMR (75 MHz, CD3OD): δ 170.9, 166.4, 146.4, 134.2, 132.2, 130.9, 129.1, 126.9, 126.5, 126.4, 123.1, 
63.8, 58.4, 52.5, 17.8. MS m/z (ESI, positive polarity): MS+23: 442.0, 420.0; MS2(420.1): 392.0; 
204.9; MS3(392.0): 346.0, 205.0, 158.9. Anal. calcd. for C18H17N3O7S: C, 51.55; H, 4.09; N, 10.02. 
Found: C, 51.78; H, 4.28; N, 9.76.  
 (3R)-3-Methyl-3-(2-nitrobenzenesulfonylamino)-1-[(S)-1-phenyl-carboxymethyl]azetidin-2-one 
(8e): The general procedure was followed (Oxidation method B) from N-hydroxy-(2S)-phenylethyl-β-
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lactam (0.740 mmol, 0.300 g). Yield: 0.180 g (58%); yellowish powder; m.p. 188-190°C; [α]D25 +66.3 
(1.25, MeOH); IR (KBr) νmax 3360, 2944, 1741, 1736, 1536, 1167, 826 cm–1; 1H NMR (500 MHz, 
CD3OD) δH 7.83−7.33 (m, 9H), 5.38 (s, 1H), 3.56 (d, 1H, J = 5.6 Hz), 3.23 (d, 1H, J = 5.6 Hz), 1.60 (s, 
3H). 13C NMR (75 MHz, CD3OD): δ 173.4, 168.1, 147.8, 135.6, 134.9, 133.6, 132.2, 130.0, 128.4, 
128.3, 127.7, 124.5, 65.0, 59.8, 52.8, 19.7. MS m/z (ESI, positive polarity): MS+23: 442.0, 420.1; 
MS2(420.1): 392.0; MS3(392.0): 346.0, 205.0, 159.0. Anal. calcd. for C18H17N3O7S: C, 51.55; H, 4.09; 
N, 10.02. Found: C, 51.32; H, 3.82; N, 9.82. 
(3R) 1-(1-Carboxy-isopropyl)-3-methyl-3-(2-nitrobenzenesulfonylamino)azetidin-2-one (8f): To 
the solution of N-(methoxycarbonyl-isopropyl)-β-lactam (0.259  mmol, 0.110 g) in THF (1 mL) was 
added a solution of LiOH⋅H2O (1.299 mmol, 0.055 g) in H2O (1 mL). The reaction mixture was stirred 
at room temperature for 2h and then was acidified with 2M HCl and extracted with EtOAc (3 x 5 mL). 
The organic layer was dried over MgSO4 and evaporated to give a product which was purified by 
column chromatography (hexanes/EtOAc, 2:1). Yield: 0.090 g (93%); yellow oil; [α]D25 −33.0 (1.2, 
MeOH); IR (KBr) νmax 3260, 2989, 1785, 1764, 1532, 1179, 816 cm–1; 1H NMR (500 MHz, CD3OD) δH 
8.16−7.78 (m, 4H), 3.68 (d, 1H, J = 5.0 Hz), 3.34 (d, 1H, J = 5.0 Hz), 1.61 (s, 3H), 1.52 (s, 3H), 1.44 (s, 
3H). 13C NMR (75 MHz, CD3OD): δ 175.9, 169.1, 149.3, 136.4, 135.0, 133.6, 131.7, 125.9, 65.6, 60.2, 
54.5, 24.3, 24.2, 20.9. MS m/z (ESI, negative polarity): MS-1: 383.0; MS2(383.0): 200.7, 185.7, 137.8; 
MS3(137.8): 117.9. Anal. calcd. for C14H17N3O7S: C, 45.28; H, 4.61; N, 11.32. Found: C, 44.97; H, 
4.77; N, 11.53. 
 
General Procedure for the Preparation of 3-Methyl-1-[(N-methylcarbamoyl)alkyl]-3-(2-
nitrobenzenesulfonylamino)azetidin-2-ones (12a-f):  To the solution of the corresponding β-lactam 8 
(0.175 mmol, 0.060 g) in THF (1.5 mL) NMM (0.175 mmol, 0.020 mL) and IBCF29 (0.175 mmol, 0.022 
mL) were successively added at −20°C. After an activation period of 3 min, 40% aqueous methylamine 
(0.350 mmol, 0.012 mL) was added and the resulting solution was stirred for 45 min at −20°C. After the 
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solvent was evaporated under reduced pressure, the residue was directly loaded on silica gel 
(hexanes/EtOAc, 1:7) to give the corresponding N-methylcarbamoyl-β-lactam. 
(3R)-3-Methyl-1-(N-methylcarbamoyl-methyl)-3-(2-nitrobenzenesulfonylamino)azetidin-2-one 
(12a): The general procedure was followed from β-lactam (8a) (0.175 mmol, 0.060 g). The obtained 
crude product was purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.050 g (80%); white 
powder; m.p. 145-147°C; [α]D25 −87.3 (1.5, CH2Cl2); IR (KBr) νmax 3108, 2990, 1760, 1732, 1526, 
1140, 825 cm–1; 1H NMR (500 MHz, CDCl3) δH 8.10−7.26 (m, 4H), 6.98 (br s, 1H),  5.95 (s, 1H), 4.35 
(d, 1H, J = 17.0 Hz), 3.89 (d, 1H, J = 5.5 Hz), 3.57 (d, 1H, J = 17.0 Hz), 3.37 (d, 1H, J = 5.5 Hz), 2.90 
(d, 3H, J = 5.5 Hz), 1.62 (s, 3H); 13C NMR (125 MHz, CDCl3) δC 167.4, 167.1, 147.6, 134.9, 133.9, 
133.2, 130.8, 125.5, 67.9, 57.4, 45.6, 26.3, 21.8. MS m/z (ESI, negative polarity): MS-1: 354.9; 
MS2(354.9): 135.8 137.7 185.7, 193.7. Anal. calcd. for C13H16N4O6S: C, 43.82; H, 4.53; N, 15.72. 
Found: C, 43.80; H, 4.69; N, 15.47. 
 (3R)-3-Methyl-1-[(1R)-1-(N-methylcarbamoyl)-ethyl]-3-(2-nitrobenzenesulfonylamino)-azetidin-
2-one (12b): The general procedure was followed from β-lactam (8b) (0.08 mmol, 0.030 g). The crude 
product was purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.018 g (58%); white solid; m.p. 
152°C; [α]D25 −67.3 (0.75, CH2Cl2); IR (KBr) νmax 3150, 2963, 1750, 1735, 1520, 1160, 825 cm–1; 1H 
NMR (500 MHz, CDCl3) δH 8.09−7.74 (m, 4H), 7.08 (br s, 1H), 5.92 (s, 1H), 4.47 (q, 1H, J = 7.3 Hz), 
3.74 (d, 1H, J = 5.5 Hz), 3.40 (d, 1H, J = 5.5 Hz), 2.88 (d, 3H, J = 4.7 Hz), 1.60 (s, 3H), 1.42 (d, 3H, J = 
7.3 Hz); 13C NMR (125 MHz, CDCl3) δC 170.1, 166.9, 147.6, 135.0, 133.9, 133.2, 130.8, 125.4, 66.5, 
53.9, 50.3, 26.4, 21.9, 14.5. MS m/z (ESI, negative polarity): MS-1: 369.0; MS2(369.0): 185.7, 137.8, 
126.8. Anal. calcd. for C14H18N4O6S: C, 45.40; H, 4.90; N, 15.11. Found: C, 45.41; H, 4.78; N, 15.20. 
(3R)-3-Methyl-1-[(1S)-1-(N-methylcarbamoyl)-ethyl]-3-(2-nitrobenzenesulfonylamino)-azetidin-
2-one (12c): The general procedure was followed from β-lactam (8c) (0.078 mmol, 0.028 g). The crude 
product was purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.017 g (59%); white solid; m.p. 
163−164°C; [α]D25 − 69.3 (0.67, CH2Cl2); IR (KBr)  νmax 3120, 2959, 1765, 1745, 1540, 1100, 808 cm–1; 
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1H NMR (500 MHz, CDCl3) δH 8.12−7.72 (m, 4H), 6.56 (br s, 1H), 5.96 (s, 1H), 4.06 (q, 1H, J = 7.3 
Hz), 3.84 (d, 1H, J = 5.5 Hz), 3.39 (d, 1H, J = 5.5 Hz), 2.84 (d, 3H, J = 4.8 Hz), 1.58 (s, 3H), 1.57 (d, 
3H, J = 7.3 Hz); 13C NMR (125 MHz, CDCl3) δC 171.1, 167.4, 148.0, 135.8, 134.2, 133.5, 131.2, 125.8, 
66.5, 55.9, 53.9, 26.8, 21.9, 15.9. MS m/z (ESI, negative polarity): MS-1: 369.0; MS2(369.0): 185.7, 
137.8, 126.9; MS3(137.0): 121.8, 90.0. Anal. calcd. for C14H18N4O6S: C, 45.40; H, 4.90; N, 15.11. 
Found: C, 45.04; H, 4.88; N, 15.23. 
(3R)-3-Methyl-1-[(1R)-1-(N-methylcarbamoyl)-1-phenyl-methyl]-3-(2-
nitrobenzenesulfonylamino)-azetidin-2-one (12d): To a solution of β-lactam (8d) (0.24 mmol, 0.100 
g) and methylamine (2M in THF; 0.357 mmol, 0.179 mL) in CH2Cl2 (5 mL) were added sequentially 
DCC (0.334 mmol, 0.069 g) and HOBt (0.286mmol, 0.039 g) at 0°C. The reaction mixture was left to 
warm up and stirred at room temperature for 12h. Then solvent was removed under reduced pressure 
and the resulting crude product was purified by preparative TLC (hexanes/EtOAc, 1:5). Yield: 0.080 g 
(78%); yellowish powder; m.p. 145°C; [α]D25 −144.4 (0.75, CH2Cl2); IR (KBr) νmax 3320, 2984, 1768, 
1732, 1540, 1158, 828 cm–1; 1H NMR (500 MHz, CDCl3) δH 8.14−7.25 (m, 10H), 5.52 (s, 1H), 3.80 (d, 
1H, J = 5.8 Hz), 2.99 (d, 3H, J = 4.7 Hz), 2.94 (d, 1H, J = 5.8 Hz), 1.46 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δC 169.1, 167.2, 147.9, 135.4, 134.3, 133.7, 131.3, 129.6, 129.2, 125.9, 66.7, 60.1, 55.3, 27.0, 
21.8; MS m/z (ESI, negative polarity): MS+1: 431.0; MS2(431.0): 193.7, 188.8, 137.8; MS3(188.8): 
137.8, 131.8. Anal. calcd. for C19H20N4O6S: C, 52.77; H, 4.66; N, 12.96. Found: C, 52.91; H, 4.70; N, 
12.61. 
(3R)-3-Methyl-1-[(1S)-1-(N-methylcarbamoyl)-1-phenyl-methyl]-3-(2-
nitrobenzenesulfonylamino)-azetidin-2-one (12e): According to the aforementioned procedure 
(compound 12d) product 12e was prepared starting from β-lactam (8e) (0.31 mmol, 0.130 g) and 
methylamine (2M in THF; 0.465 mmol, 0.233 mL). An epimerization took place, and the mixture of 
diastereisomers 12e and 12d (ratio 96:4) was separated by preparative TLC (hexanes/EtOAc, 1:5). 
Yield: 0.113 g (85%); yellowish powder; m.p. 148-150°C; [α]D25 +38.9 (0.7, CH2Cl2); IR (KBr) νmax 
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3210, 2943, 1745, 1725, 1544, 1164, 821 cm–1; 1H NMR (500 MHz, CDCl3) δH 7.92−7.35 (m, 10H), 
5.99 (br s, 1H), 5.93 (br s, 1H), 5.38 (s, 1H), 3.62 (s, 2H), 2.79 (d, 3H, J = 4.7 Hz), 1.62 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δC 168.7, 167.1, 147.5, 135.3, 133.9, 133.5, 132.9, 130.7, 129.2, 128.9, 128.4, 
125.3, 65.9, 59.2, 54.8, 26.4, 21.3. MS m/z (ESI, negative polarity): MS-1: 431.0; MS2(431.0): 137.8, 
188.8, 185.7. Anal. calcd. for C19H20N4O6S: C, 52.77; H, 4.66; N, 12.96. Found: C, 53.00; H, 4.59; N, 
12.58. 
(3R)-3-Methyl-1-[1-(N-methylcarbamoyl)-isopropyl]-3-(2-nitrobenzenesulfonylamino)azetidin-2-
one (12f): The β-lactam (8f) (0.162 mmol, 0.160 g) was dissolved in CH2Cl2 (2.5 mL) and cooled to 0 
ºC. To this solution methylamine (2 M THF) (0.323 mmol, 0.162 mL) was added and then the reaction 
mixture was cooled to –12ºC (ice/NaCl) and EEDQ (0.072g, 0.292 mmol) was added as a CH2Cl2 
solution (2.5 mL). The reaction was slowly warmed to room temperature and stirred overnight. After 
this time, the reaction mixture was concentrated under reduced pressure and the crude product was 
purified by preparative TLC (hexanes/EtOAc, 1:7) to afford pure N-methylamide 12f as a white powder. 
Yield: 0.050 g (75%); m.p. 135°C; [α]D25 −46.2 (1.75, CH2Cl2); IR (KBr) νmax 3315, 2934, 1758, 1728, 
1540, 1166, 798 cm–1; 1H NMR (500 MHz, CD3OD) δH 8.14−7.84 (m, 4H), 3.63 (d, 1H, J = 5.0 Hz), 
3.41 (d, 1H, J = 5.0 Hz), 2.79 (s, 3H,), 1.57 (s, 3H), 1.54 (s, 3H), 1.45 (s, 3H); 13C NMR (125 MHz, 
CD3OD) δC 174.5, 168.3, 148.2, 135.4, 134.1, 132.6, 130.2, 124.8, 64.8, 60.2, 53.8, 25.8, 23.4, 23.3, 
20.1. MS m/z (ESI, negative polarity): MS-1: 383.0; MS2(383.0): 200.7, 185.7, 137.8; MS3(137.8): 
117.9. Anal. calcd. for C15H20N4O6S: C, 46.87; H, 5.24; N, 14.57. Found: C, 47.02; H, 5.33; N, 14.36. 
 
General Procedure for the Preparation 3-Acetamido-3-methyl-1-[(N-methylcarbamoyl)-alkyl]-
azetidin-2-ones (5a-f): To a stirred solution of the corresponding β-lactam 12 (0.067 mmol, 0.045 g) in 
dry CH3CN (5 mL) thiophenol (0.335 mmol, 0.034 g) and K2CO3 (0.268 mmol, 0.037 g) were added. 
After stirring at room temperature for 1 h (monitoried by TLC and 1H NMR) acetic anhydride (0.402 
mmol, 0.088 g) was added and reaction was stirred overnight. The solvent was evaporated under 
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reduced pressure and crude was purified by preparative TLC (hexanes/EtOAc, 1:7). 
(R)-3-Acetamido-3-methyl-1-[1-(N-methylcarbamoyl)methyl]azetidin-2-one (5a): The general 
procedure was followed from  α-(2-nosyl)-β-lactam 12a (0.084 mmol, 0.030 g). The crude product was 
purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.015 g (84%); yellowish oil; [α]D25 +94.8 
(0.5, CH2Cl2); IR (KBr) νmax 3210, 2965, 1740, 1728 cm–1; 1H NMR (500 MHz, CDCl3) δH 8.19 (br s, 
1H),  6.16 (s, 1H), 4.44 (d, 1H, J = 17.6 Hz), 3.89 (d, 1H, J = 5.0 Hz), 3.57 (d, 1H, J = 17.6 Hz), 3.37 (d, 
1H, J = 5.0 Hz), 2.90 (d, 3H, J = 4.6 Hz), 2.06 (s, 3H), 1.58 (s, 3H); 13C NMR (125 MHz, CDCl3) δC 
170.7, 168.8, 168.0, 65.0, 53.5, 45.3, 26.3, 22.9, 20.5. MS m/z (ESI, negative polarity): MS-1: 211.8; 
MS2(212.0): 181.8, 169.8, MS3(169.8): 126.8, 112.8, 100.8, 96.0, 82.9. Anal. calcd. for C9H15N3O3: C, 
50.69; H, 7.09; N, 19.71. Found: C, 50.72; H, 7.35; N, 19.62. 
(3R)-3-Acetamido-3-methyl-1-[1-(1R)-(N-methylcarbamoyl)ethyl]azetidin-2-one (5b): The 
general procedure was followed from α-(2-nosyl)-β-lactam 12b (0.064 mmol, 0.024 g). The crude 
product was purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.010 g (72%); yellowish solid; 
m.p. 159-160°C; [α]D25 +58.2 (0.5, CH2Cl2); IR (KBr) νmax 3125, 3060, 1782, 1768 cm–1; 1H NMR (500 
MHz, CDCl3) δH 8.13 (br s, 1H), 5.96 (s, 1H), 4.47 (q, 1H, J = 7.3 Hz), 3.73 (d, 1H, J = 5.1 Hz), 3.23 (d, 
1H, J = 5.1 Hz), 2.84 (d, 3H, J = 4.6 Hz), 2.04 (s, 3H), 1.55 (s, 3H), 1.40 (d, 3H, J = 7.3 Hz); 13C NMR 
(125 MHz, CDCl3) δC 170.6, 168.6, 63.5, 50.2, 49.8, 26.5, 23.0, 20.7, 14.4. MS m/z (ESI, negative 
polarity): MS-1: 225.9; MS2(225.9): 183.8; MS3(183.8): 126.8, 96.9. Anal. calcd. for C10H17N3O3: C, 
52.85; H, 7.54; N, 18.49. Found: C, 52.86; H, 7.60; N, 18.53. 
 (3R)-3-Acetamido-3-methyl-1-[1-(1R)-(N-methylcarbamoyl)ethyl]azetidin-2-one (5c): The 
general procedure was followed from α-(2-nosyl)-β-lactam 12c (0.060 mmol, 0.022 g). The crude 
product was purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.011 g (81%); white powder; 
m.p. 115°C; [α]D25 +58.6 (0.5, CH2Cl2); IR (KBr) νmax 3310, 3140, 1785, 1758 cm–1; 
1H NMR (500 
MHz, CDCl3) δH 8.01 (br s, 1H), 5.96 (s, 1H), 3.80 (d, 1H, J = 5.0 Hz), 3.75 (q, 1H, J = 7.4 Hz), 3.17 (d, 
1H, J = 5.0 Hz), 2.86 (d, 3H, J = 4.7 Hz), 2.03 (s, 3H), 1.73 (d, 3H, J = 7.5 Hz), 1.55 (s, 3H); 13C NMR 
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(125 MHz, CDCl3) δC 171.4, 170.5, 168.6, 63.4, 56.2, 53.5, 26.4, 23.0, 20.6, 16.3. MS m/z (Ion Source 
Type: ESI, negative polarity): MS-1: 225.9; MS2(225.9): 195.8, 183.8; MS3(183.8): 126.8, 96.9. Anal. 
calcd. for C10H17N3O3: C, 52.85; H, 7.54; N, 18.49. Found: C, 52.59; H, 7.68; N, 18.84. 
(3R)-3-Acetamido-3-methyl-1-[1-(1R)-(N-methylcarbamoyl)phenylmethyl]azetidin-2-one (5d): 
The general procedure was followed from α-(2-nosyl)-β-lactam 12d (0.108 mmol, 0.047 g). The crude 
product was purified by preparative TLC (CH2Cl2/MeOH 10:1). Yield: 0.028 g (89%); white powder; 
m.p. 99°C; [α]D25 +21.2 (0.5, CH2Cl2); IR (KBr) νmax 3125, 3094, 1760, 1725 cm–1; 1H NMR (500 MHz, 
CDCl3) δH 8.44 (br s, 1H), 7.37-7.22 (m, 5H),  5.99 (br s, 1H), 5.50 (s, 1H), 3.73 (d, 1H, J = 5.0 Hz), 
2.95 (d, 3H, J = 4.6 Hz), 2.72 (d, 1H, J = 5.0 Hz), 2.00 (s, 3H), 1.38 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δC 170.9, 169.2, 168.3, 134.3, 129.0, 128.9, 128.4, 63.4, 59.4, 51.3, 26.6, 22.9, 20.2. MS m/z 
(Ion Source Type: ESI, negative polarity): MS−1: 288.1; MS2(288.0): 245.8, 230.8, 171.8, 126.8, 111.9; 
MS3(245.8): 126.8; MS4(126.8): 111.8, 98.9. Anal. calcd. for C15H19N3O3: C, 62.27; H, 6.62; N, 14.52. 
Found: C, 62.40; H, 6.51; N, 14.75. 
(3R)-3-Acetamido-3-methyl-1-[1-(1S)-(N-methylcarbamoyl)phenylmethyl]azetidin-2-one (5e): 
The general procedure was followed from α-(2-nosyl)-β-lactam 12e (0.144 mmol, 0.062 g). The crude 
product was purified by preparative TLC (CH2Cl2/MeOH 10:1). Yield: 0.039 g (94%); white crystals; 
m.p. 198-199°C; [α]D25 +133.5 (0.75, MeOH); IR (KBr) νmax 3210, 2998, 1744, 1725 cm–1; 1H NMR 
(500 MHz, CDCl3) δH 7.43-7.39 (m, 5H), 7.14 (br s, 1H), 5.66 (s, 1H), 5.77 (s, 1H), 3.77 (d, 1H, J = 5.0 
Hz), 3.46 (d, 1H, J = 5.0 Hz), 2.93 (d, 3H, J = 4.7 Hz), 2.02 (s, 3H), 1.58 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δC 170.1, 168.9, 168.3, 134.6, 128.8, 128.7, 128.5, 76.6, 63.4, 62.3, 53.9, 26.5, 23.0, 20.4. MS 
m/z (Ion Source Type: ESI, negative polarity): MS-1: 288.1; MS2(288.0): 245.8, 230.8, 188.8, 171.8, 
126.8; MS3(245.8): 126.8; MS4(126.8): 111.8, 58.3. Anal. calcd. for C15H19N3O3: C, 62.27; H, 6.62; N, 
14.52. Found: C, 62.67; H, 6.70; N, 14.30. 
(3R)-3-Acetamido-3-methyl-1-[1-(N-methylcarbamoyl)isopropyl]azetidin-2-one (5f): The general 
procedure was followed from α-(2-nosyl)-β-lactam 12f (0.091 mmol, 0.035 g). The crude product was 
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purified by preparative TLC (hexanes/EtOAc, 1:7). Yield: 0.018 g (82%); yellowish powder; m.p. 216-
218°C [α]D25 +57.7 (0.75, CH2Cl2); IR (KBr) νmax 3320, 3180, 1769, 1748 cm–1; 
1H NMR (500 MHz, 
CDCl3) δH 8.28 (br s, 1H), 6.30 (s, 1H), 3.73 (d, 1H, J = 5.0 Hz), 3.20 (d, 1H, J = 5.0 Hz), 2.82 (d, 3H, J 
= 4.6 Hz), 2.02 (s, 3H), 1.71 (s, 3H), 1.52 (s, 3H), 1.36 (s, 3H); 13C NMR (125 MHz, CDCl3) δC 173.7, 
170.7, 168.3, 62.2, 60.3, 51.0, 26.6, 24.8, 24.3, 22.9, 20.7. MS m/z (Ion Source Type: ESI, positive 
polarity): MS+23: 264.0, 242.0; MS2(242.0): 129.0; MS3(129.0): 101.1, 58.4. Anal. calcd. for 
C11H19N3O3: C, 54.76; H, 7.94; N, 17.42. Found: C, 54.50; H, 8.00; N, 17.09. 
 
General Procedure for the Preparation of Ns-(β-Lactam)-Aa-Aib-OBn Compounds (13b-e): To 
a stirred solution of the corresponding N-carboxymethyl β-lactam 9b-e (1 mmol) in CH2Cl2 (20 mL) 
cooled to −0°C was added H-Aib-OBn (1 mmol, 0.193 g) dissolved in CH2Cl2 (9 mL). The solution was 
cooled to −12 °C, EEDQ (1.2 mmol, 0.310 g) was added and the reaction mixture was slowly warmed 
to room temperature and stirred overnight. The resulting solution was washed with 1M HCl (3x10 mL), 
the aqueous layer was extracted with CH2Cl2 and the combined organic phases were dried (MgSO4) and 
evaporated. The product was purified by flash column chromatography (hexanes/EtOAc, 2:1). 
Compound 13b: The general procedure was followed from the N-carboxyalkyl-β-lactam 9b (1 mmol, 
0.433 g); Yield: 0.486 g (79%); white solid; m.p. 216-218ºC; [α]D25 +54.7 (0.42, CH2Cl2); IR (KBr) νmax 
3396, 3085, 1762, 1681, 1539, 1347, 1153 cm–1; 1H NMR (500 MHz, CDCl3) δH 8.15-7.72 (m, 4H, o-
Ns), 7.37-7.21 (m, 10H, Ar), 7.17 (s, 1H, NHCMe2), 5.89 (s, 1H, NH-Ns), 5.21 (d, 1H, J = 12.3 Hz, 
OCH2Ph), 5.09 (d, 1H, J = 12.6 Hz, OCH2Ph), 4.32 (m, 1H, NCHMe), 3.55 (d, 1H, J = 5.7 Hz, 
CH2NCO), 3.34 (d, 1H, J = 5.7 Hz, CH2NCO), 3.14 (d, 1H, J = 13.5 Hz, NCCH2Ph), 3.03 (d, 1H, J = 
13.5 Hz NCCH2Ph), 1.59 (s, 3H, Me2C), 1.56 (s, 3H, Me2C), 0.83 (d, 3H, J = 6.9 Hz, MeCHNH); 13C 
NMR (125 MHz, CDCl3) δC 173.8, 168.8, 166.1, 147.4, 134.9, 133.8, 133.2, 132.6, 130.9, 130.2, 128.9, 
128.5, 128.2, 128.1, 125.3, 70.1, 67.0, 56.6, 50.5, 49.5, 40.3, 25.4, 24.7, 13.4. MS m/z (Ion Source 
Type: ESI, positive polarity): MS+23: 264.0, 242.0; MS2(242.0): 129.0; MS3(129.0): 101.1, 58.4. Anal. 
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calcd. for C30H32N4O8S: C, 59.20; H, 5.30; N, 9.20. Found: C, 58.86; H, 5.64; N, 9.01. 
Compound 13c: The general procedure was followed from the N-carboxyalkyl-β-lactam 9b (1 mmol, 
0.433 g). Yield: 0.426 g (70%); white solid; m.p. 216-218ºC; [α]D25 +106.7 (0.3, CH2Cl2); IR (KBr) νmax 
3378, 3105, 1748, 1539, 1356, 1165 cm–1. 1H NMR (500 MHz, CDCl3) δH 8.14-7.74 (m, 4H, o-Ns), 
7.40-7.25 (m, 10H, Ar), 6.93 (s, 1H, NHCMe2), 5.86 (s, 1H, NH-Ns), 5.18 (s, 2H, OCH2Ph), 3.89 (q, 
1H, J = 1.6 Hz, NCH(Me)CO), 3.72 (d, 1H, J = 5.7 Hz, CH2NCO), 3.47 (d, 1H, J = 5.7 Hz, CH2NCO), 
3.14 (q, 2H, J = 1.6 Hz, CqCH2Ph), 1.59 (s, 3H, Me2C), 1.58 (s, 3H, Me2C), 1.46 (d, 3H, J = 7.25 Hz, 
MeCHNH); 13C NMR (125 MHz, CDCl3) δC 173.9, 169.5, 166.5, 147.4, 133.6, 133.2, 133.1, 130.9, 
130.0, 129.0, 128.5, 128.2, 128.1, 127.9, 125.3, 69.5, 67.2, 56.6, 53.8, 53.5, 40.6, 29.7, 24.9, 15.1. MS 
m/z (TOF MS ES+): MS[+Na]: 630.9, MS[+H]: 608.8, MS: 562.8, 500.9, 472.9, 394.0, 359.9, 115.9. 
Anal. calcd. for C30H32N4O8S: C, 59.20; H, 5.30; N, 9.20. Found: C, 59.14; H, 5.55; N, 8.92. 
Compound 13d: The general procedure was followed from the N-carboxyalkyl-β-lactam 9d (1 mmol, 
0.497 g). Yield: 0.368 g (55%); white solid; m.p. 72−74°C; [α]D25 −83.8 (0.65, CH2Cl2); IR (KBr) νmax 
3378, 3028, 1768, 1742, 1677, 1534, 1148 cm–1; 1H NMR (500 MHz, CDCl3) δH 8.15−7.68 (m, 4H), 
7.50−6.85 (m, 15H), 5.90 (br s, 1H), 5.32 (s, 1H), 5.20 (d, 1H, J = 12.5 Hz), 5.16 (d, 1H, J = 12.5 Hz), 
3.69 (d, 1H, J = 6.0 Hz), 3.04 (d, 1H, J = 6.0 Hz), 3.00 (d, 1H, J = 14.0 Hz), 2.95 (d, 1H, J = 14.0 Hz), 
1.67 (s, 3H), 1.64 (s, 3H); 13C NMR (125 MHz, CDCl3) δC 173.8, 167.8, 165.9, 147.5, 136.0, 134.8, 
134.0, 133.4, 133.3, 132.5, 131.1, 130.1, 129.1, 128.9, 128.7, 128.6, 128.5, 128.2, 128.1, 128.0, 125.5, 
69.9, 67.2, 59.2, 55.9, 52.3, 40.3, 25.5, 24.9. MS m/z (Ion Source Type: ESI, positive polarity): MS: 
693.2; MS2(693.2): 671.2, 666.1, 665.2, 478.3; MS3(665.2): 479.2, 478.2, 463.1. Anal. calcd. for 
C35H34N4O8S: C, 62.67; H, 5.11; N, 8.35. Found: C, 62.60; H, 4.95; N, 8.07. 
Compound 13e: The general was followed from the N-carboxyalkyl-β-lactam 9e (0.42 mmol, 0.2 g) 
and α-aminoisobutyric acid benzyl ester (0.44 mmol; 0.085 g). Yield: 0.023 g (66%); m.p. 64−65°C; 
[α]D25 +9.4 (0.65, CH2Cl2); IR (KBr) νmax 3350, 2928, 1744, 1726, 1682, 1536, 1148 cm–1; 1H NMR 
(500 MHz, CDCl3) δH 7.95−7.61 (m, 4H); 7.37−7.26 (m, 15H), 6.44 (br s, 1H), 5.81 (br s, 1H), 5.33 (s, 
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1H), 5.19 (d, 1H, J = 12.5 Hz), 5.15 (d, 1H, J = 12.5 Hz), 3.76 (d, 1H, J = 5.5 Hz), 3.52 (d, 1H, J = 5.5 
Hz), 3.25 (dd, 2H, J = 11.9 Hz), 1.59 (s, 3H), 1.56 (s, 3H); 13C NMR (125 MHz, CDCl3) δC 173.9, 
167.4, 166.7, 147.3, 135.6, 135.3, 133.6, 133.5, 133.0, 131.1, 129.9, 129.2, 129.1, 129.0, 128.7, 128.5, 
128.2, 127.9, 125.4, 69.3, 67.5, 59.7, 57.1, 53.6, 41.1, 25.0, 24.5. MS m/z (Ion Source Type: ESI, 
positive polarity): MS: 693.3; MS2(693.2): 666.1, 665.2, 478.2, 361.2; MS3(665.2): 479.1, 478.2, 
463.2. Anal. calcd. for C35H34N4O8S: C, 62.67; H, 5.11; N, 8.35. Found C, 62.32; H, 5.06; N, 7.98. 
 
General Procedure for the Preparation of Boc-(β-Lactam)-Aa-Aib-OH Compounds 6b-e: 
Thiophenol (5.00 mmol, 0.469 mL) and K2CO3 (4.00 mmol, 0.567 g) were added to a solution of the 
corresponding Ns-(β-Lactam)-Aa-Aib-OBn 13b-e (1 mmol) in dry MeCN (15 mL) and the suspension 
was stirred at room temperature for 2 h (monitoried by TLC and 1H NMR). Upon completion, the 
reaction mixture was filtered through a pad of celite, evaporated in vacuo and quickly purified by 
column chromatography (CH2Cl2, then MeOH). The corresponding intermediate amine H-(β-Lactam)-
Aa-Aib-OBn was redissolved in MeCN (15 mL), di-tert-butyldicarbonate (0.402 mmol; 0.088 g) was 
added and the solution was stirred overnight at room temperature. The solution was evaporated, treated 
with saturated aqueous NaHCO3 and extracted with CH2Cl2 (3 x 10 mL). The combined organic 
solutions were dried (MgSO4) and the solvents were evaporated under reduced pressure to afford the 
corresponding intermediate Boc-(β-Lactam)-Aa-Aib-OBn, which was purified by preparative TLC 
(hexanes/EtOAc, 2:1). This benzyl ester was dissolved in ethanol (15 mL) containing 10%Pd/C (0.050 
g), and the suspension was stirred at room temperature under hydrogen for 16 h. After this time, the 
reaction mixture was filtered through a pad of celite, washed with ethanol (2 x 10 mL), and the 
combined organic solution was evaporated under reduced pressure to afford the corresponding carboxyl 
peptide product 6b-e. 
2-{2-[(3R)-3-Benzyl-3-(tert-butoxycarbonylamino)-2-oxoazetidin-1-yl]-(R)-propanamido}-2-
methylpropanoic acid (6b) : The general procedure was followed from compound 13b (1 mmol, 0.608 
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g). Overall yield: 0.342 g (79%); Oil; [α]D25 –15.0 (0.2, CH2Cl2); IR (KBr) νmax 3320, 3180, 1769, 1748 
cm–1. 1H NMR (500 MHz, CD3OD) δH 7.31-7.29 (m, 5H, Ar), 4.0 (m, 1H, CHMe), 3.67 (d, 1H, J = 4.8 
Hz, CH2NCO), 3.35 (d, 1H, J = 4.8 Hz, CH2NCO), 3.07 (d, 1H, J = 13.3 Hz, CH2Ph), 2.97 (d, 1H, J = 
13.3 Hz, CH2Ph), 1.47 (s, 9H, tBuO), 1.46 (s, 6H, Me2CH), 0.58 (d, 3H, J = 7.1 Hz, MeCH); 13C NMR 
(125 MHz, CD3OD) δC 181.2, 171.2, 171.0, 156.6, 135.6, 131.8, 129.4, 128.4, 81.0, 68.8, 59.5, 50.8, 
39.1, 28.7, 26.9, 25.8, 13.9. HPLC-MS, MeOH/HCO2H m/z (ESI, positive polarity): MS+23: 264.0, 
242.0; MS2(242.0): 129.0; MS3(129.0): 101.1, 58.4. Anal. calcd. for C22H31N3O6: C, 60.95; H, 7.21; N, 
9.69. Found C, 61.33; H, 6.95; N, 9.60.  
2-{2-[(3R)-3-Benzyl-3-(tert-butoxycarbonylamino)-2-oxoazetidin-1-yl]-(S)-propanamido}-2-
methylpropanoic acid (6c) : The general procedure was followed from compound 13c (1 mmol, 0.608 
g). Overall yield: 0.346 g (80%); white solid; m.p. 216-218ºC; [α]D25 –28.1 (0.36, CH2Cl2); IR (KBr) 
νmax 2974, 1739, 1698, 1583, 1363, 1166 cm–1; 1H NMR (500 MHz, CDCl3) δH 7.77 (s, 1H, NHCMe2), 
7.39-7.19 (m, 5H, Ar), 4.9 (s, 1H, BocHN), 4.34 (m, 1H, CHMe), 3.65 (d, 1H, J = 4.4 Hz, CH2NCO), 
3.38 (d, 1H, J = 5.4 Hz, CH2NCO), 3.19 (d, 1H, J = 13.5 Hz, CH2Ph), 2.94 (d, 1H, J = 13.5 Hz, CH2Ph), 
1.55 (s, 3H, Me2C), 1.55 (s, 3H, Me2C), 1.45 (s, 9H, tBuO), 0.85 (d, 3H, J = 7.25 Hz, MeCH); 13C NMR 
(125 MHz, CDCl3) δC 180.6, 170.2, 169.8, 155.5, 134.6, 130.7, 128.4, 127.4, 79.9, 67.7, 58.4, 49.8, 
38.1, 29.7, 27.7, 25.8, 24.8, 12.9. HRMS (TOF CI) m/z: 433.2221; C22H31N3O6 requires: 433.2216. 
2-{[(3R)-3-Benzyl-3-(tert-butoxycarbonylamino)-2-oxoazetidin-1-yl]-(R)-phenylacetamido}-2-
methylpropanoic acid (6d) : The general procedure was applied from β-lactam 13d (1.00 mmol, 0.670 
g). Yield: 0.355 g (82%); white solid; mp = 238 °C; [α]D25 +35.8 (0.65, MeOH); IR (KBr) νmax 3320, 
2928, 2851, 1744, 1686, 1670, 1651 cm–1; 1H NMR (500 MHz, CD3OD) δH 7.32−6.64 (m, 10H), 5.03 
(s, 1H), 3.58 (d, 1H, J = 5.5 Hz), 3.02 (d, 1H, J = 13.5 Hz), 2.85 (d, 1H, J = 13.5 Hz), 2.83 (d, 1H, J = 
5.5 Hz), 1.61 (s, 3H), 1.57 (s, 3H), 1.50 (s, 9H); 13C NMR (125 MHz, CD3OD) δC 176.8, 169.7, 168.9, 
155.4, 133.7, 133.6, 130.3, 128.7, 128.3, 127.8, 127.2, 79.8, 67.6, 58.6, 56.8, 48.5, 27.3, 25.4, 23.7. 
HPLC-MS, MeOH/HCO2H m/z (ESI, positive polarity): 566.4; MS2(566.4): 436.1, 435.0, 434.2, 374.1, 
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202.1; MS3(434.2): 375.1, 374.1, 188.0, 187.0, 178.0, 173.0, 172.0, 159.0, 131.0, 130.0; MS4(374.1): 
188.0, 187.0, 172.0, 170.0, 159.0, 130.9. Anal. calcd. for C27H33N3O6: C, 65.44; H, 6.71; N, 8.48. Found 
C, 65.30; H, 6.49; N, 8.13. 
2-{[(3R)-3-Benzyl-3-(tert-butoxycarbonylamino)-2-oxoazetidin-1-yl]-(S)-phenylacetamido}-2-
methylpropanoic acid (6e): The general procedure was applied from β-lactam 13e (1.00 mmol, 0.670 
g). Yield: 0.346 g (80%); mp 113−115 °C; [α]D25 +44.5 (0.3, MeOH); IR (KBr) νmax 3326, 2980, 2916, 
2853, 1744, 1698, 1674, 1660 cm–1; 1H NMR (500 MHz, DMSO-d6) δH 8.41 (s, 1H), 7.30−7.22 (m, 
10H), 5.29 (s, 1H), 3.48 (br s, 1H), 3.32 (br s, 1H), 3.17−3.10 (br s, 2H), 1.36 (br s, 15H). 13C NMR (75 
MHz, DMSO-d6): δ 176.8, 168.1, 167.3, 154.8, 136.3, 136.1, 130.5, 128.7, 128.5, 128.4, 128.1, 127.0, 
79.2, 67.5, 58.4, 56.0, 51.4, 38.8, 28.6, 25.2, 25.0. HPLC-MS m/z (ESI, negative polarity): 494.3; 
MS2(494.3): 420.0; MS3(420.0): 377.0, 334.0, 333.1, 291.0, 273.0, 260.9, 249.9, 248.0, 174.8, 127.9; 
MS4(377.0): 333.0, 275.9, 249.9, 247.9, 207.0, 159.9, 127.9 188.0, 187.0, 172.0, 170.0, 159.0, 130.9. 
Anal. calcd. for C27H33N3O6: C, 65.44; H, 6.71; N, 8.48. Found C, 65.14; H, 6.98; N, 8.20. 
Preparation of 2-{[(3R)-3-Benzyl-3-(tert-butoxycarbonylamino)-2-oxoazetidin-1-yl]-
dimethylacetamido}-2-methylpropanoic acid (6f). 
(3R)-3-Benzyl-3-tert-butoxycarbonyl-1-[1-(methoxycarbonyl)isopropyl]-azetidin-2-one. 
Thiophenol (5 mmol, 0.469 mL) and K2CO3 (4 mmol, 0.567 g) were added to a solution of (3R)-3-
benzyl-3-(2-nitrobenzenesulfonylamino)-1-[1-(methoxycarbonyl)isopropyl]-azetidin-2-one1 (1 mmol, 
0.461 g) in MeCN (5 mL). The suspension was stirred for 2 h at r.t., the solvent was evaporated in 
vacuo and the residue was purified by column chromatography (EtOAc, then MeOH) to afford (3R)-3-
benzyl-3-amino-1-[1-(methoxycarbonyl)isopropyl]-azetidin-2-one in 90% yield (0.248 g). To a solution 
of this material in CH2Cl2 (5 mL) was added (Boc)2O (3 mmol, 0.654g) and the mixture was stirred at 
r.t. for 16 h. After evaporation of the solvent, the crude was purified by column chromatography 
hexanes/EtOAc, 5:1). Overall yield: 0.188 g (50%); Yellow oil; [α]D25 +10.2 (0.6, CH2Cl2); IR (KBr) 
νmax 3318, 1760, 1742, 1714 cm–1; 1H NMR (500 MHz, CDCl3) δH 7.38-7.25 (m, 5H, Ph), 4.78 (s, 1H, 
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NH), 3.66 (s, 3H, OCH3), 3.58 (d, 1H, J = 5.2 Hz, CH2NCO), 3.38 (d, 1H, J = 5.2 Hz, CH2NCO), 3.11 
(s, 2H, CH CH2Ph), 1.48 (s, 9H, tBuO), 1.35 (s, 3H, CMe2), 1.21 (s, 3H, CMe2). 13C NMR (75MHz, 
CDCl3): 173.2, 166.9, 153.4, 135.3, 130.3, 128.4, 127.1, 65.8, 58.8, 52.6, 49.9, 39.1, 28.2, 23.7, 23.6. 
MS m/z (ESI, positive polarity): +MS2: 343.1, +MS4: 283.0. Anal. calcd. for C20H28N2O5: C, 63.81; H, 
7.50; N, 7.44. Found: C, 63.64; H, 7.36; N, 7.19. 
Compound (6f): To a solution of (3R)-3-benzyl-3-tert-butoxycarbonyl-1-[1-(methoxy 
carbonyl)isopropyl]-azetidin-2-one (1 mmol, 0.376 g) in MeOH (20 mL) was added LiOH.H2O (10 
mmol, 0.485 g) in 10 mL of H2O and the mixture was stirred at r.t. for 4h. Acidification of the resulting 
mixture with 1M HCl and extraction with CH2Cl2 (3 x 8 mL) provided an organic solution of (3R)-3-
benzyl-3-tert-butoxycarbonyl-1-[1-(carboxy)isopropyl]-azetidin-2-one, which was dried (Na2SO4) and 
filtered. H-Aib-OBn (1.3 mmol, 0.248 g) was added, the mixture was cooled to –12ºC and EEDQ (1.3 
mmol, 0.331 g) was added. The reaction mixture was stirred during 16 h, while reaching r.t. slowly. The 
resulting solution was washed with 1M HCl (3x10 mL), the aqueous layer was extracted with CH2Cl2 
and the combined organic phases were dried (MgSO4) and evaporated. The crude was purified by flash 
column chromatography (hexanes/EtOAc, 5:1) affording benzyl 2-{[(3R)-3-benzyl-3-(tert-
butoxycarbonylamino)-2-oxoazetidin-1-yl]-dimethylacetamido}-2-methylpropanoate; white solid; 0.494 
g (92%). A suspension of this benzyl ester (0.92 mmol) and 20%-Pd/C in EtOAc (35 mL) was stirred 
for 1h at r.t. in H2 atmosphere. The mixture was filtered through a celite pad and the filtrate was 
evaporated. Yield: 0.411 g (100%); white solid; m.p. 213-215ºC; [α]D25 +65.2 (0.48, CH2Cl2); IR (KBr): 
3346, 1736, 1702, 1685 cm–1; 1H NMR (500 MHz, CDCl3) δH 7.87 (s, 1H, NHCMe2), 7.38-7.27 (m, 5H, 
Ar), 4.84 (s, 1H, BocNH), 3.62 (d, 1H, J = 5.1 Hz, CH2NCO), 3.35 (d, 1H, J = 5.1 Hz, CH2NCO), 3.14 
(d, 1H, J = 13.4 Hz, CH2Ph), 2.89 (d, 1H, J = 13.4 Hz, CH2Ph), 1.58 (s, 3H, Me2C), 1.57 (s, 3H, Me2C), 
1.45 (s, 9H, tBuO), 1.32 (s, 3H, Me2C), 0.95 (s, 3H, Me2C). 13C NMR (75MHz, CDCl3): 175.8, 174.5, 
168.3, 154.7, 133.5, 130.8, 129.1, 128.2, 81.6, 66.4, 59.9, 57.9, 48.6, 39.5, 28.7, 25.9, 25.3, 24.4, 23.8. 
MS m/z (ESI, positive polarity): MS: 446.2, MS2(446.2): 372.8, 372.1, MS3(372.1): 329.0, 
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MS4(329.0): 329.1, 242.9, 201.9, 199.9, 172.0, 168.9, 153.9, 127.9, 111.0. Anal. calcd. for C23H33N3O6: 
C, 61.73; H, 7.43; N, 9.39. Found: C, 62.04; H, 7.39; N, 8.93. 
 
General Procedure for the Preparation of Boc-Ala-(α-Bn-β-Lactam)-Aib-OMe Compounds 15-
16: Thiophenol (5 mmol, 0.469 mL) and K2CO3 (4 mmol, 0.567 g) were added to a stirred solution of 
(3R)-3-benzyl-1-[1-(methoxycarbonyl)isopropyl]-3-(2-nitrobenzenesulfonylamino)-azetidin-2-one 14 (1 
mmol, 0.461 g) in MeCN (5 mL). The mixture was stirred over 2 h, the solvent was evaporated in vacuo 
and the crude was purified by flash column chromatography (EtOAc, then MeOH). Yield: 90%. A 
solution of the resulting amine and the corresponding Boc-Ala-OH (1.3 mmol, 0.248 g) in anhydrous 
CH2Cl2 (20 mL) was cooled to –12ºC and EEDQ (1.3 mmol, 0.331 g) was added. The mixture was 
stirred during 16 h, while reaching r.t. slowly. The resulting solution was washed with 1M HCl (3x10 
mL), the aqueous layer was extracted with CH2Cl2 and the combined organic phases were dried 
(MgSO4) and evaporated. The product was purified by flash column chromatography (hexanes/EtOAc, 
2:1). 
Methyl 2-{[(3R)-3-benzyl-3-[2-(tert-butoxycarbonylamino)-(2R)-propanamido]-2-oxoazetidin-1-
yl]-2-methylpropanoate (15): The general procedure was followed from compound 17 (1 mmol, 0.461 
g) and Boc-D-Ala-OH (1.3 mmol, 0.248 g). Yield: 0.371 g (83%); white solid; m.p. 135-137ºC; [α]D25 
+28.5 (0.2, CH2Cl2); IR (KBr) ν 3309, 3000, 1763, 1752, 1704, 1656, 1160, 672 cm–1; 1H NMR (500 
MHz, CDCl3) δH 7.28-7.32 (m, 5H, Ar), 6.62 (bs, 1H, CONHCCH2Ph), 4.9 (bs, 1H, 
CONHCH(CH3)CO), 4.14 (m, 1H, NHCH(Me)CO), 3.71 (s, 3H, CO2Me), 3.63 (d, 1H, J = 5.5 Hz, 
NCH2CCH2Ph), 3.45 (d, 1H, J = 5.4 Hz, NCH2CCH2Ph), 3.21 (d, 1H, J = 14.2 Hz, CH2Ph), 3.18 (d, 1H, 
J = 14.0 Hz, CH2Ph), 1.45 (s, 9H, tBuO), 1.43 (s, 3H, Me2CCO2Me), 1.36 (s, 3H, Me2CCO2Me), 1.31 
(d, 3H, J = 7.1 Hz, CH(Me)CONH). 13C-NMR (75MHz, CDCl3): 173.1, 172.7, 166.8, 155.3, 134.8, 
130.2, 128.4, 127.2, 80.2, 65.7, 58.9, 52.5, 49.4, 38.7, 28.3, 23.6, 18.3, 16.8. HPLC-MS, MeOH/HCO2H 
m/z (ESI, positive polarity): 187.1(35), 133.1(99), 126.1(62), 112.1(41), 97.1(41), 72.1(85), 59.1(100), 
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57.1(48), 55.1(53). HRMS (TOF CI) m/z: 447.2372; C23H33N3O6 requires: 447.2369. 
 
 Methyl 2-{[(3R)-3-benzyl-3-[2-(tert-butoxycarbonylamino)-(2S)-propanamido]-2-oxoazetidin-1-
yl]-2-methylpropanoate (16): The general procedure was followed from compound 17 (1 mmol, 0.461 
g) and Boc-Ala-OH (1.3 mmol, 0.248 g). Yield: 0.380 g (85%); yellowish solid; [α]D25 –22.4 (0.5, 
CH2Cl2); IR (KBr) ν 3271, 2993, 1753, 1721, 1716, 1673, 1167, 740 cm–1; 1H NMR (500 MHz, CDCl3) 
δH 7.32 (m, 5H, Ar), 4.08 (m, 1H, COCH(Me)NH), 3.65 (s, 3H, CO2Me), 3.59 (d, 1H, J = 5.5 Hz, 
NCH2C), 3.41 (d, 1H, J = 5.3 Hz, NCH2C), 3.15 (dd, 2H, J = 13.7 Hz, CH2Ph), 1.45 (s, 9H, tBuO), 1.33 
(s, 3H, CMe2CO2Me), 1.29 (d, 1H, J = 6.9 Hz, CHMeNH), 1.23 (s, 3H, CMe2CO2Me); 13C-NMR 
(75MHz, CDCl3): 173.2, 172.9, 155.3, 134.9, 130.3, 128.4, 127.1, 79.6, 65.9, 58.9, 53.5, 52.5, 49.8, 
38.5, 28.3, 23.4, 18.3. HPLC-MS, MeOH/HCO2H m/z (ESI, positive polarity): 187.1(32), 134.1(28), 
133.1(100), 115.6(27), 102.5(21), 92.1(33), 91.1(41), 58(56). HRMS (TOF CI) m/z: 447.2348; 
C23H33N3O6 requires: 447.2369. 
 
General Procedure for the Preparation of Boc-Ala-(β-Lactam)-Aib-Ala-NH2 Compounds 7a-d: 
To a solution of the corresponding methyl 2-{[(3R)-3-benzyl-3-[2-(tertbutoxycarbonylamino)-2R-
propanamido]-2-oxoazetidin-1-yl]-2-dimethylpropanoate 15 or 16 (1 mmol, 0.447 g) in MeOH (20 mL) 
was added a solution of LiOH⋅H2O (10 mmol, 0.485 g) in MeOH/H2O 10:5 mL. The mixture was stirred 
for 2 h, it was acidified with 1M HCl (5 mL) and the aqueous phase was extracted with CH2Cl2 (3 x 15 
mL) to afford the intermediate carboxylic acid in 85% yield. To this crude material dissolved in 
anhydrous DMF (15 mL) cooled to 0ºC was added successively the corresponding alaninamide (1.5 
mmol, 0.131 g), HATU (1.5 mmol, 0.570 g), HOAT (1.4 mmol, 0.191 g) and KHCO3 (15 mmol, 1.5 g). 
The mixture was stirred during 16 h while allowing it to reach r.t. slowly. The solvent was evaporated at 
low pressure, the residue was redissolved in CH2Cl2 and it was washed with 1M HCl (3 x 10 mL) and 
sat NaHCO3 (3 x 10 mL). After evaporation of the organic solvent, the crude product was purified by 
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flash column chromatography (hexanes/EtOAc, 5:1 or CH2Cl2/MeOH, 15:1). 
2-(2-{(3R)-Benzyl-3-[2-(tert-butoxycarbonylamino)-(2R)-propanamido]-2-oxoazetidin-1-yl}-2-
methylpro panamido)-(2R)-propanamide (7a): The general procedure was followed from methyl 2-
{[(3R)-3-benzyl-3-[2-(tert-butoxycarbonylamino)-(2R)-propanamido]-2-oxoazetidin-1-yl]-2-
dimethylpropanoate 15 (1 mmol, 0.447 g) and (R)-alaninamide 18 (1.5 mmol, 0.131 g). Yield: 0.629 g 
(80%); white solid; m.p. 190-192°C; [α]D25 +36.0 (0.30, CH2Cl2); IR (KBr) νmax 3416, 3308, 2965, 
1741, 1726, 1694, 1536, 691 cm–1; 1H NMR (500 MHz, DMSO-d6) δH 8.3 (s, 1H, NHCCH2Ph), 8.16 (d, 
1H, J = 6.9 Hz, NHCH(Me)CONH2), 7.33-7.28 (m, 5H, Ph), 7.1 (bs, 1H, NH2), 6.87 (d, 1H, J = 8.1 Hz, 
BocNH), 6.83 (bs, 1H, NH2), 4.13 (m, 1H, BocHNCH(Me), 4.06 (m, 1H, CH(Me)CONH2), 3.58 (d, 1H, 
J = 5.1 Hz, CH2NCMe2), 3.26 (d, 1H, J = 5.0 Hz, CH2NCMe2), 3.05 (d, 1H, J = 13.4 Hz, CH2Ph), 3.02 
(d, 1H, J = 13.5 Hz, CH2Ph), 1.39 (s, 9H, tBuO), 1.29 (d, 3H, J = 7.2 Hz, CH(Me)CONH2), 1.20 (d, 3H, 
J = 6.9 Hz, BocHNCH(Me), 1.12 (s, 3H, Me2CCO), 0.7 (s, 3H, Me2CCO). 13C-NMR (75MHz, CDCl3): 
175.0, 173.6, 173.2, 166.8, 156.1, 133.1, 130.3, 128.7, 127.8, 80.9, 77.2, 65.8, 59.8, 49.6, 38.9, 28.3, 
24.3, 23.6, 15.9, 16.5. HPLC-MS, MeOH/ HCO2H m/z (ESI, positive polarity): 217.2 (19), 167.1 (33), 
149.0 (100), 119.1 (26), 85.9 (29). Anal. Calcd. for C25H37N5O6: C, 59.63; H, 7.41; N, 13.91. Found: C, 
59.70; H, 7.01; N, 13.91. HRMS (TOF CI) m/z: 503.2763; requires: 503.2744. 
2-(2-{(3R)-Benzyl-3-[2-(tert-butoxycarbonylamino)-(2R)-propanamido]-2-oxoazetidin-1-yl}-2-
methylpro panamido)-(2S)-propanamide (7b): The general procedure was followed from methyl 2-
{[(3R)-3-benzyl-3-[2-(tert-butoxycarbonylamino)-(2R)-propanamido]-2-oxoazetidin-1-yl]-2-
dimethylpropanoate 15 (1 mmol, 0.447 g) and (S)-alaninamide 18 (1.5 mmol, 0.131 g). Yield: 0.327 g 
(65%); white solid; m.p. 202-204ºC; [α]D25 –80.0 (0.50, CH2Cl2); IR (KBr) νmax 3412, 3213, 1733, 1730, 
1681, 1629, 696, 734 cm–1; 1H-NMR (500MHz, DMSO-d6): 8.41 (s, 1H, NHCCH2Ph), 8.30 (d, 1H, J = 
6.7 Hz, NHCH(Me)CONH2), 7.33-7.28 (m, 5H, Ph), 7.10 (s, 1H, NH2), 6.88 (d, 1H, J = 7.8 Hz, 
NHBoc), 6.84 (s, 1H, NH2), 4.13 (m, 1H, tBuOCONHCHMe), 4.06 (m, 1H, CH(Me)CONH2), 3.58 (d, 
1H, J = 5.3 Hz, CH2NCMe2), 3.26 (d, 1H, J = 5.0 Hz, CH2NCMe2), 3.06 (d, 1H, J = 13.4 Hz, CH2Ph), 
Page 36 of 43
ACS Paragon Plus Environment
The Journal of Organic Chemistry
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 37 
3.02 (d, 1H, J = 13.6 Hz, CH2Ph), 1.39 (s, 9H, tBuO), 1.29 (d, 3H, J = 7.1 Hz, CH(Me)CONH2), 1.20 
(d, 3H, J = 6.9 Hz, BocHNCH(Me), 1.09 (s, 3H, Me2CCO), 0.75 (s, 3H, Me2CCO). 13C-NMR (75MHz, 
CDCl3): 175.2, 175.1, 173.5, 173.3, 167.0, 156.1, 133.1, 130.3, 128.7, 127.8, 80.8, 77.2, 65.8, 59.8, 
49.7, 47.5, 38.8, 28.3, 24.3, 16.6. HPLC-MS, MeOH/HCO2H m/z (ESI, positive polarity): 119.1(88), 
97.1(60), 91.1(72), 71.1(67), 69.1(63), 57.1(100), 55.1(90). HRMS (TOF CI) m/z: 503.2727; 
C25H37N5O6 requires: 503.2744. 
2-(2-{(3R)-Benzyl-3-[2-(tert-butoxycarbonylamino)-(2S)-propanamido]-2-oxoazetidin-1-yl}-2-
methylpro panamido)-(2S)-propanamide (7c): The general procedure was followed from methyl 2-
{[(3R)-3-benzyl-3-[2-(tert-butoxycarbonylamino)-(2S)-propanamido]-2-oxoazetidin-1-yl]-2-
dimethylpropanoate 16 (1 mmol, 0.447 g) and (S)-alaninamide 18 (1.5 mmol, 0.131 g). Yield: 0.326 g 
(73%); yellowish solid; m.p. 160-162ºC; [α]D25 +66.0 (0.20, CH2Cl2); IR (KBr) νmax 3334, 2969, 1748, 
1682, 1536, 1165 cm–1; 1H NMR (500 MHz, DMSO-d6) δH 8.32 (s, 1H, NHCCH2Ph), 8.16 (d, 1H, J = 
6.5 Hz, NHCH(Me)CONH2), 7.33-7.28 (m, 5H, Ph), 7.06 (bs, 1H, NH2), 6.91 (d, 1H, J =7.0 Hz, 
NHBoc), 6.77 (bs, 1H, NH2), 4.08 (m, 1H, BocNHCHMe), 4.02 (m, 1H, CH(Me)CONH2), 3.61 (d, 1H, 
J = 4.7 Hz, CH2NCMe2), 3.24 (d, 1H, J = 4.8 Hz, CH2NCMe2), 3.05 (d, 1H, J = 13.4 Hz, CH2Ph), 3.01 
(d, 1H, J = 13.5 Hz, CH2Ph), 1.38 (s, 9H, tBuO), 1.31 (d, 3H, J = 7.2 Hz, CH(Me)CONH2), 1.20 (d, 3H, 
J = 7.2 Hz, BocNHCHMe), 1.12 (s, 3H, Me2CCO), 0.7 (s, 3H, Me2CCO). 13C-NMR (75MHz, CDCl3): 
175.0, 173.6, 173.0, 166.7, 155.9, 133.0, 130.3, 128.7, 127.8, 80.9, 75.8, 65.9, 59.8, 49.6, 47.6, 38.9, 
28.3, 24.3, 23.6, 16.5. HPLC-MS, MeOH/HCO2H m/z (ESI, positive polarity): 187.1(49), 133.1(37), 
91.1(100), 70.1(60), 57.1(42). Anal. Calcd. for C25H37N5O6: C, 59.63; H, 7.41; N, 13.91. Found: C, 
59.85; H, 7.34; N, 13.92. HRMS (TOF CI) m/z: 503.2771; requires: 503.2744. 
2-(2-{(3R)-Benzyl-3-[2-(tert-butoxycarbonylamino)-(2S)-propanamido]-2-oxoazetidin-1-yl}-2-
methylpro panamido)-(2R)-propanamide (7d): The general procedure was followed from methyl 2-
{[(3R)-3-benzyl-3-[2-(tert-butoxycarbonylamino)-(2S)-propanamido]-2-oxoazetidin-1-yl]-2-
dimethylpropanoate 16 (1 mmol, 0.447 g) and (R)-alaninamide 18 (1.5 mmol, 0.131 g). Yield: 0.392 g 
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(77%); yellowish solid; m.p. 219-220ºC; [α]D25 –15.9 (0.20, CH2Cl2); IR (KBr) νmax 3413, 3303, 2978, 
2914, 1744, 1663, 1542 cm–1; 1H NMR (500 MHz, DMSO-d6) δH 8.53 (s, 1H, NHCCH2Ph), 8.37 (d, 1H, 
J = 7.3 Hz, NHCH(Me)CONH2), 7.33-7.28 (m, 5H, Ar), 7.03 (d, 1H, J = 6.7 Hz, BocNH), 6.97 (s, 1H, 
NH2), 6.88 (s, 1H, NH2), 4.04 (m, 1H, BocNHCHMe), 4.03 (m, 1H, CH(Me)CONH2), 3.46 (d, 1H, J = 
4.8 Hz, CH2NCMe2), 3.34 (d, 1H, J = 5.0 Hz, CH2NCMe2), 3.06 (d, 1H, J = 13.4 Hz, CH2Ph), 3.01 (d, 
1H, J = 13.4 Hz, CH2Ph), 1.38 (s, 9H, tBuO), 1.31 (d, 3H, J = 7.2 Hz, CH(Me)CONH2), 1.19 (d, 3H, J = 
7.0 Hz, BocHNCHMe), 0.97 (s, 3H, Me2CCO), 0.79 (s, 3H, Me2CCO). 13C-NMR (75MHz, CDCl3): 
175.9, 173.4, 172.5, 167.7, 155.9, 132.7, 130.3, 128.8, 127.9, 80.8, 77.2, 65.6, 58.9, 49.5, 48.1, 38.8, 
28.3, 23.7, 17.3. HPLC-MS, MeOH/HCO2H m/z (ESI, positive polarity): 187.1 (44), 173.1 (28), 172.1 
(26), 117.1 (37), 116 (25), 115 (26), 113.1 (35), 91 (100), 70.0 (47). Anal. Calcd. for C25H37N5O6: C, 
59.63; H, 7.41; N, 13.91. Found: C, 59.21; H, 7.60; N, 13.79. HRMS (TOF CI) m/z: 503.2742; requires: 
503.2744. 
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